Results 181 to 190 of about 23,963 (194)

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Lancet Neurology, The, 2014
Peter A Calabresi, Douglas S Goodin, Anthony T Reder   +2 more
exaly  

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder

Multiple Sclerosis Journal, 2012
Ju-Hong Min
exaly  

Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy

Journal of the Neurological Sciences, 2013
Yasuyuki Kihara, Jerold Chun
exaly  

The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis

CNS Drugs, 2015
Samuel F Hunter, Anthony T Reder
exaly  

Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion

Circulation, 2016
Carlos Garcia Santos-Gallego, Torsten P Vahl, Kiyotake Ishikawa   +2 more
exaly  

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

Nature Reviews Drug Discovery, 2010
exaly  

Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage

Experimental Neurology, 2013
Paul R Krafft, Yu Hasegawa, Orhan Altay
exaly  

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study

Lancet Neurology, The, 2011
Frederik Barkhof, Giancarlo Comi, Ludwig Kappos   +2 more
exaly  

Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair

Molecular Therapy, 2017
Yuan Zhang, Bogoljub Ciric, Bruno Gran
exaly  

Fingolimod for Multiple Sclerosis

New England Journal of Medicine, 2012
exaly